- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Checkpoint Therapeutics Inc (CKPT)
Checkpoint Therapeutics Inc stock price live, this page displays NASDAQ CKPT stock exchange data. View the CKPT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Checkpoint Therapeutics Inc real time stock price chart below.
What Is the Checkpoint Therapeutics Inc Stock Price Today?
The Checkpoint Therapeutics Inc stock price today is 4.150.
What Is the Stock Symbol for Checkpoint Therapeutics Inc?
The stock ticker symbol for Checkpoint Therapeutics Inc is CKPT.
Is CKPT the Same as $CKPT?
$CKPT is a common way to refer to the Checkpoint Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Checkpoint Therapeutics Inc Trade On?
Checkpoint Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Checkpoint Therapeutics Inc a Good Stock to Buy?
Determining whether Checkpoint Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Checkpoint Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CKPT quote. (ISIN: US1628282063)
What Is the Checkpoint Therapeutics Inc Stock Price Today?
The Checkpoint Therapeutics Inc stock price today is 4.150.
What Is the Stock Symbol for Checkpoint Therapeutics Inc?
The stock ticker symbol for Checkpoint Therapeutics Inc is CKPT.
Is CKPT the Same as $CKPT?
$CKPT is a common way to refer to the Checkpoint Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Checkpoint Therapeutics Inc Trade On?
Checkpoint Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Checkpoint Therapeutics Inc a Good Stock to Buy?
Determining whether Checkpoint Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Checkpoint Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CKPT quote. (ISIN: US1628282063)
NASDAQ
Currency in USD
4.150
0.000(0.00%)
Closed·
After Hours
4.1500.000(0.00%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.150
4.160
52 wk Range
1.740
4.500
CKPT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
CKPT is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.1504.160
52 wk Range
1.7404.500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CKPT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
4.333
Upside
+4.42%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
- Checkpoint Therapeutics CEO sells stock for $60,963
- Investing.com
- Checkpoint Therapeutics CEO sells stock for $60,963
- Investing.com
Checkpoint Therapeutics Inc Company Profile
Checkpoint Therapeutics, Inc., a commercial -stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. The company’s lead antibody product candidate is UNLOXCYT, which is in Phase 1 clinical trial to treat patients with selected recurrent or metastatic cancers; and CK-302, a product candidate in preclinical trials for hematological malignancies and solid tumors. It also developing Olafertinib, which is in Phase 3 clinical trials for the treatment of adult patients with metastatic non-small cell lung cancer; CK-103 for the treatment of various advanced and metastatic solid tumor cancers; and Anti-Carbonic Anhydrase IX (CAIX) antibody, a product candidate in preclinical trials to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. It has licensing and collaboration agreements with Adimab, LLC for the development of Cosibelimab; NeuPharma, Inc., to develop and commercialize Olafertinib; and Jubilant Biosys Limited for the development and commercialization of novel compounds that inhibit BET bromodomains, as well as collaboration with Dana-Farber Cancer Institute, Inc. Checkpoint Therapeutics, Inc. was incorporated in 2014 and is based in Waltham, Massachusetts.
Compare CKPT to Peers and Sector
Metrics to compare | CKPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCKPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −6.2x | −9.1x | −0.5x | |
PEG Ratio | −0.37 | 0.01 | 0.00 | |
Price / Book | 21.3x | 1.3x | 2.6x | |
Price / LTM Sales | 8,478.5x | 5.9x | 2.9x | |
Upside (Analyst Target) | −1.2% | 276.9% | 45.8% | |
Fair Value Upside | Unlock | 15.2% | 8.6% | Unlock |
Analyst Ratings
1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 4.333
(+4.42% Upside)
Earnings
Latest Release
May 15, 2023
EPS / Forecast
-0.89 / -1.07
Revenue / Forecast
35.00K / 20.00K
People Also Watch
FAQ
What Is the Checkpoint Therapeutics (CKPT) Stock Price Today?
The Checkpoint Therapeutics stock price today is 4.15
What Stock Exchange Does Checkpoint Therapeutics Trade On?
Checkpoint Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Checkpoint Therapeutics?
The stock symbol for Checkpoint Therapeutics is "CKPT."
What Is the Checkpoint Therapeutics Market Cap?
As of today, Checkpoint Therapeutics market cap is 347.62M.
What Is Checkpoint Therapeutics's Earnings Per Share (TTM)?
The Checkpoint Therapeutics EPS (TTM) is -1.22.
From a Technical Analysis Perspective, Is CKPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.